Cutaneous adverse events associated with Rybrevant based on FDA adverse event reporting system (FAERS) database from 2021 to 2024

Naunyn-Schmiedeberg s Archives of Pharmacology 2026

View at publisher

Authors: Yuqin Zeng, Yidan Li, Ziye Du, Risheng Shu, Chuhan Fu, Qinghai Zeng

DOI: 10.1007/s00210-026-05168-1

Cited by: 2

References: 36

Fields of Study & Subjects

Colorectal Cancer Treatments and Studies Autoimmune Bullous Skin Diseases Pharmacovigilance and Adverse Drug Reactions

References 36